| abstract |
The present invention relates to (E) -N- {4- [3-chloro-4- (2-pyridinylmethoxy) anilino] -3-cyano-7-ethoxy- (NERATINIB) in the form of a maleic acid salt of a crystalline maleate salt, degradation products, impurities and pharmaceutical compositions containing such maleate salts, . Maleate salts are useful in the treatment of cancer, particularly those affected by the kaineis of epidermal growth factor receptor family. |